Inhibition of HIV protease by monoclonal antibodies
β Scribed by P. Rezacova; J. Brynda; M. Fabry; M. Horejsi; R. Stouracova; J. Lescar; V. Chitarra; M. M. Riottot; J. Sedlacek; G. A. Bentley
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 272 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0952-3499
- DOI
- 10.1002/jmr.587
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The protease of HIV plays a critical role in the maturation of the infectious particles of the virus. The enzyme has therefore been extensively studied with the objective of developing therapeutics that inhibit viral proliferation. We have produced monoclonal antibodies specific for the HIVβ1 protease, and selected those that inhibit enzyme function for use as probes to study the enzyme's activity and as an eventual aid for the development of potential inhibitors targeted to regions other than the active site. We have characterized two such mAbs, F11.2.32 and 1696, which have inhibition constants in the low nanomolar range and which recognize epitopes from different regions of the protease. The crystal structures of the two antibodies, both in the free state as well as complexes with peptide fragments corresponding to their respective epitopes, have been solved. The structural analyses, taken together with other functional data on the antibodies, suggest mechanisms of protease inhibition by these antibodies. Copyright Β© 2002 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract Murine monoclonal antibodies (Mabs) to the major core protein p24 of the human immunodeficiency virus type 1 (HIVβ1) were tested for their ability to inhibit the replication and spread __of__ the virus in permanent cell cultures (Molt4/8, K37, H9) and in the culture of 11β2 stimulated T
## Abstract F11.2.32, a monoclonal antibody directed against the HIVβ1 protease, displays strong inhibitory effects toward the catalytic activity of the enzyme. The antibody crossβreacts with peptides 36β46 and 36β57 from the protease. Crystals of the Fab have been obtained both in the free state a
Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessible inorganic drug prototypes in principle, their full potential can only be tapped by enhancing the